BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21734342)

  • 1. Mcl-1 expression is up-regulated in malignancies of the parotid gland.
    Heiduschka G; Erovic BM; Pammer J; Kotowski U; Kaider A; Ch Grasl M; Thurnher D
    Dis Markers; 2011; 30(5):229-33. PubMed ID: 21734342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
    Glas AS; Hollema H; Nap RE; Plukker JT
    Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Mcl-1 expression in rectal cancer in relation to neo-adjuvant radiotherapy.
    Ulrich-Pur H; Erovic BM; Soleiman A; Jech B; Pennwieser W; Czembirek C; Zielinski CC; Thurnher D
    Wien Klin Wochenschr; 2005 Feb; 117(4):136-40. PubMed ID: 15847193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of overexpression of myeloid cell leukemia-1-long in prognosis of malignant pleomorphic adenoma].
    Hao JQ; Fan XH; Li JY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Mar; 55(3):153-158. PubMed ID: 32193910
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclooxygenase-2 regulates the degree of apoptosis by modulating bcl-2 protein in pleomorphic adenoma and mucoepidermoid carcinoma of the parotid gland.
    Sakamoto T; Uozaki H; Kondo K; Imauchi Y; Yamasoba T; Sugasawa M; Kaga K
    Acta Otolaryngol; 2005 Feb; 125(2):191-5. PubMed ID: 15880952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of cyclooxygenase-2 in adenocarcinoma of the parotid gland: insights into malignant transformation of pleomorphic adenoma.
    Sakamoto T; Kondo K; Yamasoba T; Sugasawa M; Kaga K
    Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):930-5. PubMed ID: 15562904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANK and RANK Ligand Expression in Parotid Gland Carcinomas.
    Franchi A; Taverna C; Simoni A; Pepi M; Mannelli G; Fasolati M; Gallo O
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):478-482. PubMed ID: 29494398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland.
    Patel RS; Rose B; Bawdon H; Hong A; Lee CS; Fredericks S; Gao K; O'Brien CJ
    Histopathology; 2007 Nov; 51(5):691-6. PubMed ID: 17927591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in human benign and malignant epithelial lesions of the parotid gland.
    Zhu Q; White FH; Tipoe GL
    Oral Oncol; 1997 Jan; 33(1):29-35. PubMed ID: 9192550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Role of Matrixins in Diagnostics of Parotid Gland Tumors.
    Kochurova EV
    Bull Exp Biol Med; 2019 Jan; 166(3):383-385. PubMed ID: 30617705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between Mcl-1 and pAKT protein expression in colorectal cancer.
    Henderson-Jackson EB; Helm J; Ghayouri M; Hakam A; Nasir A; Leon M; Bui M; Yeatman T; Coppola D
    Int J Clin Exp Pathol; 2010 Oct; 3(8):768-74. PubMed ID: 21151390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.
    Christe A; Waldherr C; Hallett R; Zbaeren P; Thoeny H
    AJNR Am J Neuroradiol; 2011 Aug; 32(7):1202-7. PubMed ID: 21724574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma ex basal cell adenoma of the parotid gland: A report of an extremely rare case.
    Kusafuka K; Kawasaki T; Nakajima T; Sugino T
    Pathol Int; 2017 Jul; 67(7):355-360. PubMed ID: 28544044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign metastasizing pleomorphic adenoma of the parotid gland: a clinicopathologic puzzle.
    Marioni G; Marino F; Stramare R; Marchese-Ragona R; Staffieri A
    Head Neck; 2003 Dec; 25(12):1071-6. PubMed ID: 14648866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Livin serves as a predictive indicator for parotid gland tumors.
    Xu H; Cheng Z; Liu DW; Chen L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5223-5228. PubMed ID: 31298372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory parotid gland carcinoma ex pleomorphic adenoma. Case study diagnosed by fine needle aspiration.
    Tamiolakis D; Chimona TS; Georgiou G; Proimos E; Nikolaidou S; Perogamvrakis G; Papadakis CE
    Stomatologija; 2009; 11(1):37-40. PubMed ID: 19423970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Values of fine-needle aspiration cytology of parotid gland tumors: A review of 996 cases at a single institution.
    Suzuki M; Kawata R; Higashino M; Nishikawa S; Terada T; Haginomori SI; Kurisu Y; Hirose Y
    Head Neck; 2019 Feb; 41(2):358-365. PubMed ID: 30548147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Features and Pathological Analysis of 43 Parotid Basal Cell Adenomas.
    Chen G; Wen X; Chen XJ; Zhang L; Lin ZT; Jing L; Wang T
    Comput Math Methods Med; 2021; 2021():7906058. PubMed ID: 34912472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular composition of basal cell adenoma of the parotid gland: an immunohistochemical analysis.
    Ogawa I; Nikai H; Takata T; Miyauchi M; Ito H; Ijuhin N
    Oral Surg Oral Med Oral Pathol; 1990 Nov; 70(5):619-26. PubMed ID: 2234882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Nrf2 in pathology of pleomorphic adenoma in parotid gland.
    Droździk A; Kowalczyk R; Jaworowska E; Urasińska E; Kurzawski M
    Med Sci Monit; 2015 Apr; 21():1243-8. PubMed ID: 25928388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.